title: Cystic fibrosis in 2016: considerable progress, but much more to do.
authors.affiliation: Imperial College London and Royal Brompton & Harefield Foundation Trust, London SW3 6LR, UK. Electronic address: j.c.davies@imperial.ac.uk.
authors.forename: Jane C
authors.initials: JC
authors.lastname: Davies
mesh_terms: D000627:Aminophenols / Q000627:therapeutic use; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000453:epidemiology; D065101:Chloride Channel Agonists / Q000627:therapeutic use; D015897:Comorbidity; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000503:physiopathology*; D006801:Humans; D011552:Pseudomonas Infections / Q000453:epidemiology; D015363:Quinolones / Q000627:therapeutic use
chemical_list: D000627:Aminophenols; D065101:Chloride Channel Agonists; D015363:Quinolones; C545203:ivacaftor